Evidence map›Paper›PMID 42657503›Full record

ArticleAllergy2026

Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants.

Ozge Ardicli, Duygu Yazici, Huseyn Babayev, Yagiz Pat, Manal Bel Imam, Hang Du, Hassan Melhem, Carina Beha, Laura Buergi, Anja Heider and 14 more

Abstract read
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ozge ArdicliSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-6077-0478
Duygu YaziciSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-9094-6542
Huseyn BabayevSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-6985-9436
Yagiz PatSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-4268-4933
Manal Bel ImamSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0002-7352-7204
Hang DuSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0009-0008-7995-0856
Hassan MelhemGastroenterology Group, Department of Biomedicine, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-9977-1328
Carina BehaSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0009-0000-2527-7178
Laura BuergiSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0009-0008-7548-5483
Anja HeiderSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0002-3448-4125
Juan-Felipe LópezSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0002-9993-9530
Sena ArdicliSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-2758-5945
Can ZeyneloğluSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0009-0008-0921-6592
Andrea KreienbühlDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.ORCID https://orcid.org/0009-0002-3564-639X
Nino StockerSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-3200-8982
Patrick WestermannSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-2894-6140
Christoph B MessnerSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-7217-0867
Mübeccel AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0003-0554-9943
Jan Hendrik NiessGastroenterology Group, Department of Biomedicine, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0001-6902-5650
Alain SchoepferDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0001-6341-9536
Luc BiedermannDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-0824-4125
Cezmi A AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-8020-019X
Swiss EoE Cohort Study Group
Willem van de VeenSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-9951-6688

Funding

Promedica Stiftung 1515/MSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_219210Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 32003B_204751/1
6 · The paper itself

Abstract

backgroundEosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by symptoms of esophageal dysfunction, such as dysphagia and food impaction, as well as eosinophilic inflammation and impaired epithelial barrier integrity, which promotes allergen influx. Environmental exposures that weaken the esophageal barrier, including surfactants found in personal care products such as sodium dodecyl sulfate (SDS) and cocamidopropyl betaine (CAPB), have been proposed as contributors to disease susceptibility. However, their direct effects on esophageal epithelial barrier function and associated molecular responses remain insufficiently characterized.

methodsWe investigated the molecular and functional consequences of SDS and CAPB exposure in primary EoE-derived esophageal organoids and air-liquid interface cultures derived from biopsy tissue samples. We conducted transepithelial electrical resistance (TEER) measurements, paracellular flux assays, RNA sequencing, targeted and untargeted proteomics, and immunofluorescence imaging.

resultsTreatment of esophageal organoids with SDS or CAPB (0-100 μg/mL) caused dose-dependent cytotoxicity and barrier disruption, with SDS producing stronger effects. At 12.5 μg/mL, viability declined to ~30% with SDS versus ~60% with CAPB, accompanied by greater TEER reduction and ~2-fold higher permeability. RNA-seq of organoids exposed to 12.5 μg/mL for 24 h showed distinct transcriptomic clustering, with 2749 shared and > 1500 surfactant-specific differentially expressed genes, indicating broad epithelial remodeling, cell-cycle suppression, and stress responses, more pronounced under SDS. SDS preferentially activated inflammatory and innate immune pathways, which was supported by proteomic detection of elevated cytokines (TNF, IL-8, IL-18, etc.). Both surfactants induced keratinization, epidermal cell differentiation, and partial epithelial-mesenchymal transition signatures, including increased vimentin without E-cadherin loss.

conclusionThese findings demonstrate that common surfactants can induce coordinated epithelial stress responses in esophageal tissue models and may act as environmental aggravating factors in EoE at relatively low doses. This work underscores the need to consider mucosal exposure to consumer product ingredients in the context of epithelial barrier disorders, particularly surfactants such as SDS and CAPB, and supports efforts to refine formulations to minimize epithelial damage.

Indexed as

Esophageal MucosaEsophagusOrganoidsSurface-Active AgentsEosinophilic EsophagitisEpithelial CellsHumansSodium Dodecyl SulfateSodium Dodecyl SulfateSurface-Active Agentscocamidopropyl betaineeosinophilic esophagitisepithelial barrier dysfunctionesophageal organoidssodium dodecyl sulfate

Identifiers

PMID42657503
PMCPMC13646889

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.